Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Completed - verified September 2013

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate Sponsor : Hoffmann-La Roche Completed - verified November 2013

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate Sponsor : Hoffmann-La Roche Recruiting - verified July 2011

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: methylprednisolone Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Completed - verified September 2013

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: methylprednisolone Sponsor : Hoffmann-La Roche Completed - verified November 2013

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: methylprednisolone Sponsor : Hoffmann-La Roche Recruiting - verified July 2011

Condition : Knee Osteoarthritis Interventions : Drug: Chondroitin sulphate (Condrosan®); Drug: Placebo Sponsor : Bioiberica Recruiting - verified August 2011

Condition : Osteoarthritis Interventions : Other: Complex Ayurvedic Treatment; Other: Conventional Care Sponsors : Charite University, Berlin, Germany; Ministry of Health & Family Welfare, India Recru...

Condition : Rheumatoid Arthritis Intervention : Drug: LY2127399 Sponsor : Eli Lilly and Company Recruiting - verified July 2011

Condition : Rheumatoid Arthritis Intervention : Drug: LY2127399 Sponsor : Eli Lilly and Company Recruiting - verified August 2011